View Financial HealthXebra Brands 배당 및 자사주 매입배당 기준 점검 0/6Xebra Brands 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jan 22Xebra Brands Ltd. announced that it expects to receive CAD 0.15 million in fundingXebra Brands Ltd. announced a non-brokered private placement that it will issue up to 3,000,000 units of the Company at a price of CAD 0.05 per unit for the gross proceeds of up to CAD 150,000 on January 22, 2025. Each Unit will consist of one common share of the Company and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of CAD 0.10 per Warrant Share at any time for a period of twenty-four months following the closing of the Offering. It is expected that the closing of the Offering will be on or about January 30, 2025, or such other date or dates that company may determine. The offering is subject to the receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company are expected to participate in the Offering.공시 • Jul 09Xebra Brands Successfully Completes First Manufacturing Run for Elements Brand Ahead of Growing Demand in MexicoXebra Brands Ltd. announced the successful completion of its first manufacturing run of its highly anticipated Elements line. This milestone represents a significant next step forward in Xebra Brands' commercialization efforts as the company prepares for initial distribution efforts in Mexico. The authorization for the importation, launch, and sale of the Elements Full Spectrum CBD Tinctures were granted to Elements Bioscience SAPI de C.V, a fully owned subsidiary of Xebra Brands Ltd, by Mexican regulatory authorities (COFEPRIS), and are expected to be sold in wellness and supplement stores, pharmacies and other retail channels which have accelerated their demand for new products.공시 • Apr 17Xebra Brands Ltd. Receives Second CBD Product Approval by COFEPRISXebra Brands Ltd. announced that it has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its second CBD product authorization to be sold in Mexico. This latest approval marks another milestone for Xebra Brands and highlights the Company's commitment to providing high-quality CBD products to consumers in Mexico. Building on the success of its first product approval in Mexico, Xebra Brands has obtained authorization for the transportation, launch, and sale of an additional 250mg Tincture, expanding its product offerings to meet the growing demand for premium CBD options in the region. Similar to its previously approved Tangerine Flavor CBD Tincture, this new product reflects Xebra's dedication to innovation, quality, and compliance within the CBD industry. Xebra Brands' 250mg Tincture is formulated with the same dedication to quality and purity as its previous offerings. Crafted with premium CBD extract, each batch of tincture undergoes thorough testing by third-party laboratories to ensure potency and consistency. This commitment to quality ensures that consumers in Mexico have access to trusted and reliable CBD products. With the approval of its second product by COFEPRIS, Xebra Brands reaffirms its position as a leader in the Mexican CBD industry. The company remains dedicated to meeting the evolving needs of consumers and providing natural wellness solutions that promote stress relief, relaxation, and overall well-being.공시 • Apr 05Xebra Brands Ltd. Submits Third Product Submission to Cofepris, Expanding Elements Brand Cbd LineupXebra Brands Ltd. announced the submission of its third product application for approval to COFEPRIS (Federal Commission for Protection Against Sanitary Risk) in Mexico for domestic production. This latest submission underscores Xebra's commitment to delivering high-quality CBD products to consumers across the country in a variety of formats. The newest addition to Xebra's Elements brand is a topical lotion meticulously crafted to provide targeted relief and nourishment for the skin, infused with premium CBD extract. Designed with precision and care, this topical lotion offers consumers a luxurious skincare experience backed by the trusted Elements brand. With the submission of the Elements Topical Lotion, Xebra now covers three major product categories in the Mexico CBD market, including topicals, tinctures, and capsules. The Company intends to continue applying for new product offerings to domestically produce products and expand into additional categories to meet the evolving needs of its consumers. Once approved by COFEPRIS, the Elements Topical Lotion will be available for purchase nationwide, providing consumers with a trusted, domestically produced solution for their skincare needs.공시 • Mar 08Xebra Brands Ltd. announced that it has received CAD 1 million in fundingOn March 7, 2024, Xebra Brands Ltd. closed the transaction. All of the units sold under the offering were purchased by David Ross Macias Diaz under a strategic investment agreement. Following the closing of the offering, David Ross Macias Diaz holds 18.04% and 30.56% of the common shares of the Company on a non-diluted basis and partially diluted basis, respectively. The offering is subject to the final acceptance of the CSE.공시 • Feb 03+ 1 more updateXebra Brands Ltd. Announces Management ChangesXebra Brands Ltd. announced a business transformation plan that will shift the Company's resources away from Canadian cannabis beverages to focus on the development and commercialization of the authorizations to manufacture cannabis products in Mexico. As part of the implementation of the Business Transformation Plan, newly appointed board member David Ross Macias Diaz has committed to an investment into the Company. Business Transformation Plan includes: Transforming the business strategy into a Mexico first model focused on generating revenues via the cannabis authorizations granted to Xebra in 2023 through partnership opportunities, listing of own products and possible M&A transactions of companies within Mexico; Scaling down the capital-intensive operations of the Company's Canadian Cannabis Beverages business; Appointing Rodrigo Gallardo as Interim-CEO to implement the Business Transformation Plan; Streamlining current corporate and operational staff to minimize cash expenditures; Realignment of current board seats from with eight (8) members to four (4) members; Revised Business Strategy. Under the Business Transformation Plan, the Company's core focus will be on commercializing the authorizations granted to Xebra an outright first-mover-advantage in Mexico, allowing Xebra and its partners to import and acquire cannabis seeds, cultivate and harvest cannabis, process and produce cannabis, and sell cannabis products both domestically and through export.공시 • Sep 21Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023.공시 • Feb 17Xebra Brands Ltd. announced that it expects to receive CAD 0.6 million in fundingXebra Brands Ltd. announced a non-brokered private placement of up to 8,000,000 units at a price of CAD 0.075 per unit for gross proceeds of up to CAD 600,000 on February 15, 2023. Each unit consists of one common share and one half of one warrant. Each whole warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.10 per share at any time within 18 months after closing. All securities to be issued in the transaction will be subject to a 4 month and one day hold period. The transaction is subject to receipt of all required regulatory and CSE approvals. The transaction is expected to close on or around March 1, 2023. The company may pay finders' fees in cash or securities, or a combination of both, as permitted by the policies of the CSE.공시 • Feb 04Xebra Brands Ltd. Appoints Keith Dolo to the Board of DirectorsXebra Brands Ltd. announced that Mr. Keith Dolo has been appointed to Xebra's Board of Directors. Keith is a seasoned cannabis executive and was formerly the Founder and CEO Sproutly Canada one of Canada's early Licensed Producers. He is a partner with venture capital firms Greenbridge Capital and Nautilus Capital, as well the Co-Founder of Maverick Brands which is a growth agency & accelerator that invests in, supports, and scales high growth brands across many different industries including the Cannabis and beverage industries. Keith was previously a VP at Robert Half International for over a decade.공시 • Jan 27+ 1 more updateXebra Announces Management ChangesXebra Brands Ltd. announced board and management changes. Robert Giustra has resigned as Chairman and Director in order to focus on his mining ventures. Mr. Giustra will remain an advisor to Xebra. Mr. Giustra is the founder of Xebra Brands; under his leadership, Xebra obtained an irrevocable injunction by the Mexican Supreme Court and created Xebra's unique beverage brands and trademarks. Over the last year Mr. Giustra transitioned the incoming CEO, and oversaw the Canadian launch of Xebra's highly successful THC and CBN infused lemonade Vicious Citrus. Daniela Freitas, Corporate Secretary have also resigned with Mr. Giustra to focus on the mining sector; Rodrigo Gallardo, Xebra's President, has been appointed CFO and Corporate Secretary on an interim basis.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 XBRA.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: XBRA.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Xebra Brands 배당 수익률 vs 시장XBRA.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (XBRA.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Pharmaceuticals)2.1%분석가 예측 (XBRA.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 XBRA.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 XBRA.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 XBRA.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: XBRA.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/23 22:06종가2026/04/21 00:00수익N/A연간 수익N/A데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Xebra Brands Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jan 22Xebra Brands Ltd. announced that it expects to receive CAD 0.15 million in fundingXebra Brands Ltd. announced a non-brokered private placement that it will issue up to 3,000,000 units of the Company at a price of CAD 0.05 per unit for the gross proceeds of up to CAD 150,000 on January 22, 2025. Each Unit will consist of one common share of the Company and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of CAD 0.10 per Warrant Share at any time for a period of twenty-four months following the closing of the Offering. It is expected that the closing of the Offering will be on or about January 30, 2025, or such other date or dates that company may determine. The offering is subject to the receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company are expected to participate in the Offering.
공시 • Jul 09Xebra Brands Successfully Completes First Manufacturing Run for Elements Brand Ahead of Growing Demand in MexicoXebra Brands Ltd. announced the successful completion of its first manufacturing run of its highly anticipated Elements line. This milestone represents a significant next step forward in Xebra Brands' commercialization efforts as the company prepares for initial distribution efforts in Mexico. The authorization for the importation, launch, and sale of the Elements Full Spectrum CBD Tinctures were granted to Elements Bioscience SAPI de C.V, a fully owned subsidiary of Xebra Brands Ltd, by Mexican regulatory authorities (COFEPRIS), and are expected to be sold in wellness and supplement stores, pharmacies and other retail channels which have accelerated their demand for new products.
공시 • Apr 17Xebra Brands Ltd. Receives Second CBD Product Approval by COFEPRISXebra Brands Ltd. announced that it has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its second CBD product authorization to be sold in Mexico. This latest approval marks another milestone for Xebra Brands and highlights the Company's commitment to providing high-quality CBD products to consumers in Mexico. Building on the success of its first product approval in Mexico, Xebra Brands has obtained authorization for the transportation, launch, and sale of an additional 250mg Tincture, expanding its product offerings to meet the growing demand for premium CBD options in the region. Similar to its previously approved Tangerine Flavor CBD Tincture, this new product reflects Xebra's dedication to innovation, quality, and compliance within the CBD industry. Xebra Brands' 250mg Tincture is formulated with the same dedication to quality and purity as its previous offerings. Crafted with premium CBD extract, each batch of tincture undergoes thorough testing by third-party laboratories to ensure potency and consistency. This commitment to quality ensures that consumers in Mexico have access to trusted and reliable CBD products. With the approval of its second product by COFEPRIS, Xebra Brands reaffirms its position as a leader in the Mexican CBD industry. The company remains dedicated to meeting the evolving needs of consumers and providing natural wellness solutions that promote stress relief, relaxation, and overall well-being.
공시 • Apr 05Xebra Brands Ltd. Submits Third Product Submission to Cofepris, Expanding Elements Brand Cbd LineupXebra Brands Ltd. announced the submission of its third product application for approval to COFEPRIS (Federal Commission for Protection Against Sanitary Risk) in Mexico for domestic production. This latest submission underscores Xebra's commitment to delivering high-quality CBD products to consumers across the country in a variety of formats. The newest addition to Xebra's Elements brand is a topical lotion meticulously crafted to provide targeted relief and nourishment for the skin, infused with premium CBD extract. Designed with precision and care, this topical lotion offers consumers a luxurious skincare experience backed by the trusted Elements brand. With the submission of the Elements Topical Lotion, Xebra now covers three major product categories in the Mexico CBD market, including topicals, tinctures, and capsules. The Company intends to continue applying for new product offerings to domestically produce products and expand into additional categories to meet the evolving needs of its consumers. Once approved by COFEPRIS, the Elements Topical Lotion will be available for purchase nationwide, providing consumers with a trusted, domestically produced solution for their skincare needs.
공시 • Mar 08Xebra Brands Ltd. announced that it has received CAD 1 million in fundingOn March 7, 2024, Xebra Brands Ltd. closed the transaction. All of the units sold under the offering were purchased by David Ross Macias Diaz under a strategic investment agreement. Following the closing of the offering, David Ross Macias Diaz holds 18.04% and 30.56% of the common shares of the Company on a non-diluted basis and partially diluted basis, respectively. The offering is subject to the final acceptance of the CSE.
공시 • Feb 03+ 1 more updateXebra Brands Ltd. Announces Management ChangesXebra Brands Ltd. announced a business transformation plan that will shift the Company's resources away from Canadian cannabis beverages to focus on the development and commercialization of the authorizations to manufacture cannabis products in Mexico. As part of the implementation of the Business Transformation Plan, newly appointed board member David Ross Macias Diaz has committed to an investment into the Company. Business Transformation Plan includes: Transforming the business strategy into a Mexico first model focused on generating revenues via the cannabis authorizations granted to Xebra in 2023 through partnership opportunities, listing of own products and possible M&A transactions of companies within Mexico; Scaling down the capital-intensive operations of the Company's Canadian Cannabis Beverages business; Appointing Rodrigo Gallardo as Interim-CEO to implement the Business Transformation Plan; Streamlining current corporate and operational staff to minimize cash expenditures; Realignment of current board seats from with eight (8) members to four (4) members; Revised Business Strategy. Under the Business Transformation Plan, the Company's core focus will be on commercializing the authorizations granted to Xebra an outright first-mover-advantage in Mexico, allowing Xebra and its partners to import and acquire cannabis seeds, cultivate and harvest cannabis, process and produce cannabis, and sell cannabis products both domestically and through export.
공시 • Sep 21Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023.
공시 • Feb 17Xebra Brands Ltd. announced that it expects to receive CAD 0.6 million in fundingXebra Brands Ltd. announced a non-brokered private placement of up to 8,000,000 units at a price of CAD 0.075 per unit for gross proceeds of up to CAD 600,000 on February 15, 2023. Each unit consists of one common share and one half of one warrant. Each whole warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.10 per share at any time within 18 months after closing. All securities to be issued in the transaction will be subject to a 4 month and one day hold period. The transaction is subject to receipt of all required regulatory and CSE approvals. The transaction is expected to close on or around March 1, 2023. The company may pay finders' fees in cash or securities, or a combination of both, as permitted by the policies of the CSE.
공시 • Feb 04Xebra Brands Ltd. Appoints Keith Dolo to the Board of DirectorsXebra Brands Ltd. announced that Mr. Keith Dolo has been appointed to Xebra's Board of Directors. Keith is a seasoned cannabis executive and was formerly the Founder and CEO Sproutly Canada one of Canada's early Licensed Producers. He is a partner with venture capital firms Greenbridge Capital and Nautilus Capital, as well the Co-Founder of Maverick Brands which is a growth agency & accelerator that invests in, supports, and scales high growth brands across many different industries including the Cannabis and beverage industries. Keith was previously a VP at Robert Half International for over a decade.
공시 • Jan 27+ 1 more updateXebra Announces Management ChangesXebra Brands Ltd. announced board and management changes. Robert Giustra has resigned as Chairman and Director in order to focus on his mining ventures. Mr. Giustra will remain an advisor to Xebra. Mr. Giustra is the founder of Xebra Brands; under his leadership, Xebra obtained an irrevocable injunction by the Mexican Supreme Court and created Xebra's unique beverage brands and trademarks. Over the last year Mr. Giustra transitioned the incoming CEO, and oversaw the Canadian launch of Xebra's highly successful THC and CBN infused lemonade Vicious Citrus. Daniela Freitas, Corporate Secretary have also resigned with Mr. Giustra to focus on the mining sector; Rodrigo Gallardo, Xebra's President, has been appointed CFO and Corporate Secretary on an interim basis.